Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2024 Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2024 Earnings Call Transcript February 25, 2025

Fresenius Medical Care AG & Co. KGaA beats earnings expectations. Reported EPS is $0.46, expectations were $0.41.

Dominik Heger – Head, IR:

Helen Giza – CEO and Chair:

A medical professional in a white coat and gloves administering dialysis treatment to a patient.

Martin Fischer – CFO:

Hassan Al-Wakeel – Barclays:

Giang Nguyen – Citigroup:

Q&A Session